Trizivir and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Trizivir (abacavir sulfate; lamivudine; zidovudine), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Truvada, and have Hepatitis b.

The phase IV clinical study analyzes which people have Hepatitis c when taking Trizivir. It is created by eHealthMe based on reports of 2,801 people who have side effects when taking Trizivir from the FDA, and is updated regularly.

What is Trizivir?

Trizivir has active ingredients of abacavir sulfate; lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 2,813 Trizivir users. Check the latest studies of Trizivir.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On May, 13, 2026

2,801 people reported to have side effects when taking Trizivir.
Among them, 21 people (0.75%) have Hepatitis c.

Among these 21 people:

How long have people been on Trizivir when they have Hepatitis c? *

What is the gender of people who have Hepatitis c when taking Trizivir? *

female: 19.05 %
male: 80.95 %

What is the age of people who have Hepatitis c when taking Trizivir? *

What are other drugs people take besides Trizivir? *

What are other side effects people have besides Hepatitis c? *

Renal Injury (kidney injury): 12 people, 57.14%
Skeletal Injury (bone and supporting muscle injury): 12 people, 57.14%
Osteoporosis (bones weak and more likely to break): 10 people, 47.62%
Spinal Disorder (disease of spine a back bone): 10 people, 47.62%
Broken Bone: 10 people, 47.62%
Bone Loss: 10 people, 47.62%
Bone Density Decreased: 10 people, 47.62%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 10 people, 47.62%
Hepatitis B: 10 people, 47.62%
Anaemia (lack of blood): 4 people, 19.05%

What are the existing conditions these people have? *

Hepatitis B: 10 people, 47.62%
Weight Loss: 1 person, 4.76%
Diabetes: 1 person, 4.76%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Trizivir and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trizivir:

Trizivir (2,813 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

How severe was Hepatitis c and when was it recovered:

Hepatitis c in Trizivir

Expand to all the drugs that have ingredients of abacavir sulfate; lamivudine; zidovudine:

Hepatitis c and drugs with ingredients of abacavir sulfate; lamivudine; zidovudine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trizivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (787 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; lamivudine; zidovudine (the active ingredients of Trizivir) and Trizivir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.